RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $370,011 | -25.8% | 123,337 | -39.2% | 0.00% | – |
Q2 2023 | $498,732 | -36.6% | 202,737 | -41.7% | 0.00% | – |
Q1 2023 | $786,196 | -53.9% | 347,874 | -28.8% | 0.00% | – |
Q4 2022 | $1,705,699 | -84.3% | 488,739 | +67.0% | 0.00% | -100.0% |
Q3 2022 | $10,831,000 | +80.9% | 292,610 | -7.2% | 0.00% | 0.0% |
Q2 2022 | $5,986,000 | -16.6% | 315,237 | +18.5% | 0.00% | 0.0% |
Q1 2022 | $7,181,000 | -44.4% | 266,065 | -53.6% | 0.00% | -50.0% |
Q4 2021 | $12,917,000 | +9.7% | 573,321 | +27.6% | 0.00% | 0.0% |
Q3 2021 | $11,777,000 | +1295.4% | 449,341 | +1604.7% | 0.00% | – |
Q2 2021 | $844,000 | +1958.5% | 26,359 | +2184.1% | 0.00% | – |
Q1 2021 | $41,000 | -89.0% | 1,154 | -90.1% | 0.00% | – |
Q4 2020 | $373,000 | -26.3% | 11,616 | -13.6% | 0.00% | – |
Q3 2020 | $506,000 | -75.4% | 13,444 | -70.7% | 0.00% | – |
Q2 2020 | $2,053,000 | +7796.2% | 45,887 | +5813.3% | 0.00% | – |
Q1 2020 | $26,000 | -90.1% | 776 | -88.5% | 0.00% | – |
Q4 2019 | $263,000 | – | 6,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
RA Capital Management | 781,290 | $29,392,000 | 0.54% |
TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |